tirzepatide injection vs ozempic Mounjaro® vs. Ozempic®: What's the Difference? Mounjaro vs. Ozempic: Effectiveness, Side

FDA have yet to make statements of their own, as far as I can tell, though I suspect they are coming

Join 20,000+ people who've taken back control of their appetite

In February 2026, the FDA publicly announced its intent to take action targeting mass-marketed, non-FDA-approved compounded GLP1 products, emphasizing that promotional claims implying equivalence to FDAapproved drugs can trigger enforcement risk

Learn how they work, side effects, and which is right for you

The typical maintenance doses for GLP-1 receptor agonists are: liraglutide 1.8 mg daily, semaglutide 1.0 mg weekly (injectable) or 14 mg daily (oral), and du...

On October 2, 2024, the FDA announced that the shortage of tirzepatide has been officially resolved